ARKG - Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
Cathie Wood remains optimistic. Her ARK Invest exchange-traded funds (ETFs) have continued to scoop up stocks during the steep downturn this year.
But she's apparently not optimistic about all of her ARK holdings. Wood is selling one high-flying stock. Here's why you should buy it instead.
Wood's ARK Genomic Revolution ETF (NYSEMKT: ARKG) sold off shares of Vertex Pharmaceuticals (NASDAQ: VRTX) earlier this month. She hasn't completely exited the position, though. ARKG still owns over 135,000 shares of the biotech stock .
For further details see:
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead